Broderick Brian C Novartis Ag Transaction History

Broderick Brian C

  • $466 Million
  • Q4 2024

A detailed history of Broderick Brian C transactions in Novartis Ag stock. As of the latest transaction made, Broderick Brian C holds 8,073 shares of NVS stock, worth $899,978. This represents 0.17% of its overall portfolio holdings.

Number of Shares
8,073
Previous 12,033 32.91%
Holding current value
$899,978
Previous $1.38 Million 43.28%
% of portfolio
0.17%
Previous 0.29%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 12, 2025
SELL
$96.78 - $117.18 $383,248 - $464,032
-3,960 Reduced 32.91%
8,073 $785,000
Q3 2024

Nov 06, 2024
SELL
$106.13 - $120.89 $719,561 - $819,634
-6,780 Reduced 36.04%
12,033 $1.38 Million
Q2 2024

Aug 12, 2024
SELL
$92.57 - $107.37 $279,653 - $324,364
-3,021 Reduced 13.84%
18,813 $2 Million
Q1 2024

May 03, 2024
SELL
$95.27 - $108.47 $583,624 - $664,487
-6,126 Reduced 21.91%
21,834 $2.11 Million
Q4 2023

Feb 13, 2024
SELL
$92.27 - $101.54 $97,344 - $107,124
-1,055 Reduced 3.64%
27,960 $2.82 Million
Q3 2023

Nov 14, 2023
BUY
$94.73 - $105.13 $134,990 - $149,810
1,425 Added 5.16%
29,015 $2.96 Million
Q2 2023

Aug 11, 2023
SELL
$92.52 - $104.91 $33,307 - $37,767
-360 Reduced 1.29%
27,590 $2.78 Million
Q1 2023

May 10, 2023
SELL
$80.03 - $92.81 $42,015 - $48,725
-525 Reduced 1.84%
27,950 $2.57 Million
Q4 2022

Feb 09, 2023
SELL
$75.55 - $92.52 $145,811 - $178,563
-1,930 Reduced 6.35%
28,475 $2.58 Million
Q3 2022

Nov 08, 2022
SELL
$74.61 - $87.26 $147,727 - $172,774
-1,980 Reduced 6.11%
30,405 $2.31 Million
Q2 2022

Jul 19, 2022
SELL
$80.52 - $93.75 $309,840 - $360,750
-3,848 Reduced 10.62%
32,385 $2.74 Million
Q1 2022

May 17, 2022
SELL
$80.11 - $90.62 $389,895 - $441,047
-4,867 Reduced 11.84%
36,233 $3.18 Million
Q4 2021

Feb 08, 2022
SELL
$79.7 - $88.13 $2.18 Million - $2.41 Million
-27,295 Reduced 39.91%
41,100 $3.6 Million
Q3 2021

Nov 10, 2021
SELL
$81.78 - $95.14 $990,274 - $1.15 Million
-12,109 Reduced 15.04%
68,395 $5.59 Million
Q2 2021

Aug 09, 2021
SELL
$85.24 - $94.15 $415,033 - $458,416
-4,869 Reduced 5.7%
80,504 $7.34 Million
Q1 2021

May 17, 2021
SELL
$83.5 - $98.47 $70,724 - $83,404
-847 Reduced 0.98%
85,373 $7.3 Million
Q4 2020

Feb 16, 2021
SELL
$78.07 - $94.43 $33,179 - $40,132
-425 Reduced 0.49%
86,220 $8.14 Million
Q3 2020

Oct 28, 2020
BUY
$82.14 - $91.0 $77,293 - $85,631
941 Added 1.1%
86,645 $7.54 Million
Q2 2020

Jul 28, 2020
SELL
$80.93 - $91.1 $55,275 - $62,221
-683 Reduced 0.79%
85,704 $7.49 Million
Q1 2020

May 07, 2020
BUY
$70.67 - $99.01 $14,982 - $20,990
212 Added 0.25%
86,387 $7.12 Million
Q4 2019

Jan 15, 2020
SELL
$84.35 - $95.37 $52,887 - $59,796
-627 Reduced 0.72%
86,175 $8.16 Million
Q3 2019

Nov 04, 2019
SELL
$85.54 - $94.26 $56,713 - $62,494
-663 Reduced 0.76%
86,802 $7.54 Million
Q2 2019

Jul 24, 2019
SELL
$75.4 - $92.8 $9,802 - $12,064
-130 Reduced 0.15%
87,465 $7.99 Million
Q1 2019

Apr 29, 2019
SELL
$75.32 - $86.15 $115,390 - $131,981
-1,532 Reduced 1.72%
87,595 $8.42 Million
Q4 2018

Jan 24, 2019
SELL
$73.66 - $82.02 $176,931 - $197,012
-2,402 Reduced 2.62%
89,127 $7.65 Million
Q3 2018

Oct 15, 2018
BUY
$66.94 - $77.43 $17,538 - $20,286
262 Added 0.29%
91,529 $7.89 Million
Q2 2018

Jul 30, 2018
BUY
$64.91 - $73.36 $66,208 - $74,827
1,020 Added 1.13%
91,267 $6.89 Million
Q1 2018

Apr 24, 2018
BUY
$70.39 - $84.15 $2,956 - $3,534
42 Added 0.05%
90,247 $7.3 Million
Q4 2017

Feb 02, 2018
SELL
$72.33 - $77.64 $291,634 - $313,044
-4,032 Reduced 4.28%
90,205 $7.57 Million
Q3 2017

Oct 26, 2017
BUY
$74.14 - $77.27 $6.99 Million - $7.28 Million
94,237
94,237 $8.09 Million

Others Institutions Holding NVS

# of Institutions
1,483
Shares Held
131M
Call Options Held
1.31M
Put Options Held
1.56M
View Full List

About NOVARTIS AG

NVS Quotes by TradingView
  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $240B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track Broderick Brian C Portfolio

Follow Broderick Brian C and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Broderick Brian C, based on Form 13F filings with the SEC.

News

Stay updated on Broderick Brian C with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email